Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Total revenue $ 2,939 $ 15,132 $ 27,446 $ 29,009
Operating expenses        
Research and development 11,822 13,211 35,913 40,880
General and administrative 4,116 4,835 13,043 13,956
Total operating expenses 15,938 18,046 48,956 54,836
Loss from operations (12,999) (2,914) (21,510) (25,827)
Interest income 55 377 503 1,332
Other expense (1,339) (55) (1,823) (203)
Net loss (14,283) (2,592) (22,830) (24,698) [1]
Other comprehensive income:        
Foreign currency translation 632 1,636 1,462 1,908
Unrealized (loss) gain on available-for-sale securities (350) 374 (249) 377
Comprehensive loss $ (14,001) $ (582) $ (21,617) $ (22,413)
Net loss per share        
Basic and diluted (USD per share) $ (0.26) $ (0.05) $ (0.42) $ (0.50)
Weighted average number of common shares outstanding        
Basic and diluted (shares) 54,340 49,353 53,976 49,805
Customer revenue        
Total revenue $ 2,578 $ 3,589 $ 22,393 $ 15,538
Collaboration revenue        
Total revenue $ 361 $ 11,543 $ 5,053 $ 13,471
[1] (1) Restated to conform to ASC 842. See accompanying Note 2.